Trial intelligence / Profile preview

Saquinavir + Zidovudine + Lamivudine in HIV

NCT00002190Phase 2Completed

Sponsor
Roche
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of saquinavir in human immunodeficiency virus infection (HIV), sponsored by Roche. Status: completed.

02

Drugs

saquinavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00002190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call